We showed that the model made accurate predictions at individual and cohort levels, around multiple features such as the evaluation of different RT/anti-PD-L1 dose sequencing and scheduling, as well as the underlying, interactive molecular and cellular marker dynamics leading to tumor size modulation. Here, CD274 is linked to neoplasm.